Page 116 - 南京医科大学自然版
P. 116

第44卷第9期
               ·1288 ·                           南 京    医 科 大 学 学         报                        2024年9月





                       Reference  [20-24]  [26]  [28-31]  [32-33]  [35-38]  [40]  [41-43]  [15]45-48]  [  [16]51]  [  [52]  [53]  [54-55]  [56-60]  [17]  [18]  [61-62]  [63]








                       significance  prognosis  diagnosis,  prognosis  prognosis  prognosis  prognosis  prognosis  prognosis,  resistance  prognosis  prognosis  NA  prognosis  stage  prognosis  prognosis stage,  NA  prognosis  stage,  NA




                       Clinical  stage,  TNM  stage,  TNM  stage,  TNM  stage,  TNM  stage,  TNM  stage,  TNM  stage,  TNM  Drug  stage,  TNM  stage,  TNM  stage,  TNM  TNM  FIGO  Enneking



                                                        EMT                              EMT           EMT
                   tumors  malignant  behaviour  stem  tumor apoptosis,  apoptosis invasion,  invasion  apoptosis invasion,  apoptosis,  invasion,  apoptosis, migration,  cycle  cell invasion,  apoptosis progression,  apoptosis invasion,  apoptosis,  invasion,  invasion  apoptosis, migration,  invasion



                SNHG20在恶性肿瘤中的研究进展  in  SNHG20  lncRNA  Biological  migration, Multiplication,  angiopoiesis differentiation,  invasion Migration,  migration, Multiplication,  migration, Multiplication,  migration, Multiplication,  migration, Multiplication,  EMT invasion, Multiplication,  invasion, Multiplication,  polarization  M1/M2  migration, Multiplication,  progression  cycle  cell Multiplication,  migration, Multiplication,  apoptosis invasion, Migration,  migration, Multiplication,















                lncRNA  of  progress  ZRANB2/  cell  p  miR⁃19b⁃3p/  miR⁃495⁃  EMT,      Wnt/β⁃catenin;



                表1  Research                     PI3K/AKT/        HBx/SNHG20/               miR⁃338⁃3p/MCL1

                   1   genes                               gsk⁃3β/β⁃catenin;             Vimentin;
                   Table  target  miR⁃4486/MDM2/p53;  miR⁃197/LIN28;  EZH2/p21;  miR⁃154  EZH2/E⁃cadhein;  DDX17  E⁃cadherin


                       Related  SNHG20/FOXK1/MMP1/MMP9/E⁃Cadherin;21  miR⁃342⁃3p/MTDH  miR⁃2467⁃3p/E2F3;  p  miR⁃140⁃5p/NDRG3  miR⁃495/STAT3  C⁃myc  E⁃cadherin,  miR⁃148a/ROCK1;  ZEB2,
                          PTEN/PI3K/AKT;  TGF⁃β1  miR⁃29a/DIXDC1/Wnt;  RAB14  miR⁃140;  miR197/Wnt/β⁃catenin;  mTOR;  ATM/JAK/PD⁃L1  EZH2/E⁃cadherin,21,  3p/ZFX;  miR⁃5095/MBD1;  STAT6 PTEN;  A1;21;  p  Cyclin  Wnt/β⁃catenin,  miR⁃6516⁃5p/SCGB2A1;  D1,  Cyclin  p21,  miR⁃217;  miR⁃140⁃5p/ADAM10  miR⁃495/HER2  miR⁃139/RUNX2;  ZEB1, Vimentin,  miR⁃335⁃5p/E2F3








                       Function  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  NA Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene  Oncogene



                       cancer                                                     cancer  cancer  cancer  cancer  cancer


                       of        Nasopharynx                                   cancer                  Osteosarcoma  Retinoblastoma
                       Type  Glioma  Cancer  OSCC  LSCC  NSCLC  ESCC  GC  HCC  CRC  Renal  Bladder  Prostatic  Ovarian  Cervical  Breast
   111   112   113   114   115   116   117   118   119   120   121